Multivalent inhibition of the Aspergillus fumigatus KDNase.
Mathieu ScalabriniDenis LoquetCamille RochardMélyne Baudin MarieCoralie AssaillyYoan BrissonnetFranck DaligaultAmélie SaumonneauAnnie LambertCyrille GrandjeanDavid DeniaudPaul LottinSagrario PascualLaurent FontaineViviane BalloySébastien G GouinPublished in: Organic & biomolecular chemistry (2024)
Aspergillus fumigatus is a saprophytic fungus and opportunistic pathogen often causing fatal infections in immunocompromised patients. Recently Af KDNAse, an exoglycosidase hydrolyzing 3-deoxy-D-galacto-D- glycero -nonulosonic acid (KDN), a rare sugar from the sialic acid family, was identified and characterized. The principal function of Af KDNAse is still unclear, but a study suggests a critical role in fungal cell wall morphology and virulence. Potent Af KDNAse inhibitors are required to better probe the enzyme's biological role and as potential antivirulence factors. In this work, we developed a set of Af KDNAse inhibitors based on enzymatically stable thio-KDN motifs. C2, C9-linked heterodi-KDN were designed to fit into unusually close KDN sugar binding pockets in the protein. A polymeric compound with an average of 54 KDN motifs was also designed by click chemistry. Inhibitory assays performed on recombinant Af KDNAse showed a moderate and strong enzymatic inhibition for the two classes of compounds, respectively. The poly-KDN showed more than a nine hundred fold improved inhibitory activity (IC 50 = 1.52 ± 0.37 μM, 17-fold in a KDN molar basis) compared to a monovalent KDN reference, and is to our knowledge, the best synthetic inhibitor described for a KDNase. Multivalency appears to be a relevant strategy for the design of potent KDNase inhibitors. Importantly, poly-KDN was shown to strongly decrease filamentation when co-cultured with A. fumigatus at micromolar concentrations, opening interesting perspectives in the development of antivirulence factors.
Keyphrases
- atrial fibrillation
- cell wall
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- candida albicans
- drug delivery
- escherichia coli
- pseudomonas aeruginosa
- peritoneal dialysis
- prognostic factors
- intensive care unit
- biofilm formation
- high throughput
- binding protein
- dna binding
- single molecule
- high intensity
- mechanical ventilation
- human health
- respiratory failure
- patient reported